Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Processa Pharmaceuticals Inc., 3 years.
Processa Pharmaceuticals Inc.
Director
Longeveron Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Processa Pharmaceuticals Inc. July 30, 2026100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 2026 | Processa Pharmaceuticals Inc. | Option exercise | +203 | — | — |
| Mar 31, 2026 | Processa Pharmaceuticals Inc. | Open-market purchase | +2,269 | $2.54 | $5,763 |
| Aug 11, 2025 | Longeveron Inc. | Open-market purchase | +11,766 | — | — |
| Jul 15, 2025 | Longeveron Inc. | Grant or award | +17,000 | — | — |
| Dec 2, 2024 | Longeveron Inc. | Open-market sale | −1,250 | $2.07 | $2,588 |
| Aug 15, 2024 | Longeveron Inc. | Grant or award | +23,500 | — | — |
| Jun 9, 2024 | Longeveron Inc. | Shares withheld for tax | −125 | $1.06 | $133 |
| Dec 29, 2023 | Longeveron Inc. | Open-market purchase | +8,322 | $1.43 | $11,900 |
| Dec 28, 2023 | Longeveron Inc. | Open-market purchase | +1,678 | $1.40 | $2,349 |
| Jun 27, 2023 | Processa Pharmaceuticals Inc. | Option exercise | +15,455 | — | — |
| Jun 9, 2023 | Longeveron Inc. | Grant or award | +5,000 | — | — |
| Feb 9, 2023 | Processa Pharmaceuticals Inc. | Grant or award | +12,500 | $0.80 | $10,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.